Cost-effectiveness and safety of interspinous process decompression (superion)

K Cairns, T Deer, D Sayed, K van Noort… - Pain Medicine, 2019 - academic.oup.com
Objective There are several treatment options for patients suffering from lumbar spinal
stenosis, including surgical and conservative care. Interspinous spacer decompression …

Clients' experiences on North America's first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study

E Oviedo-Joekes, S Dobischok, J Carvajal… - BMC Health Services …, 2023 - Springer
Background To support public health measures during the COVID-19 pandemic, oral opioid
agonist treatment (OAT) take-home doses were expanded in Western countries with positive …

Association of disability with mortality from opioid overdose among US Medicare adults

YF Kuo, MA Raji, JS Goodwin - JAMA network open, 2019 - jamanetwork.com
Importance Patients qualifying for Medicare disability have the highest rates of opioid use
compared with older Medicare beneficiaries and commercial insurance beneficiaries …

Independent and joint contributions of physical disability and chronic pain to incident opioid use disorder and opioid overdose among Medicaid patients

KL Hoffman, F Milazzo, NT Williams… - Psychological …, 2024 - cambridge.org
BackgroundChronic pain has been extensively explored as a risk factor for opioid misuse,
resulting in increased focus on opioid prescribing practices for individuals with such …

Substance use disorders among Medicare beneficiaries: prevalence, mental and physical comorbidities, and treatment barriers

WJ Parish, TL Mark, EM Weber… - American journal of …, 2022 - Elsevier
Introduction This study aimed to determine the prevalence of treated and untreated
substance use disorders among Medicare beneficiaries, the characteristics of Medicare …

Buprenorphine after nonfatal opioid overdose: reduced mortality risk in medicare disability beneficiaries

H Samples, MA Nowels, AR Williams, M Olfson… - American Journal of …, 2023 - Elsevier
Introduction Opioid-involved overdose mortality is a persistent public health challenge, yet
limited evidence exists on the relationship between opioid use disorder treatment after a …

Racial And Ethnic Disparities In Buprenorphine Receipt Among Medicare Beneficiaries, 2015–19: Study examines racial and ethnic disparities in the receipt of …

J Miles, P Treitler, J Lloyd, H Samples, A Mahone… - Health …, 2023 - healthaffairs.org
We examined Medicare Part D claims from the period 2015–19 to identify state and national
racial and ethnic disparities in buprenorphine receipt among Medicare disability …

Examining differences in prescription opioid use behaviors among US adults with and without disabilities

S Reif, EA Lauer, RS Adams, DL Brucker, GA Ritter… - Preventive …, 2021 - Elsevier
We aimed to identify differences in prescription opioid-related behaviors between adults with
and without disabilities in the US We analyzed data from the 2015–2017 National Survey on …

Racial/ethnic disparities in timely receipt of buprenorphine among Medicare disability beneficiaries

J Miles, P Treitler, R Hermida, AN Nyaku… - Drug and Alcohol …, 2023 - Elsevier
Abstract Background Medicare disability beneficiaries (MDBs) have disproportionately high
risk of opioid use disorder (OUD) and related harms given high rates of comorbidities and …

The cost of opioid use disorder-related conditions in Medicare

TL Mark, WJ Parish, EM Weber, DG Steinberg… - Drug and alcohol …, 2023 - Elsevier
Background Medicare coverage excludes some levels of substance use disorder (SUD)
care, such as intensive outpatient and residential treatment. Expanding access to SUD …